WhitTier Trust Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

WhitTier Trust Company’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70	Closed	-$22.6K	–	1223
2023 Q4	$22.6K	Hold	70	–	–	﹤0.01%	813
2023 Q3	$25.1K	Sell	70 -1	-1%	-$386	﹤0.01%	775
2023 Q2	$26.9K	Buy	71 +1	+1%	+$407	﹤0.01%	795
2023 Q1	$33.5K	Hold	70	–	–	﹤0.01%	751
2022 Q4	$29.4K	Hold	70	–	–	﹤0.01%	771
2022 Q3	$29K	Hold	70	–	–	﹤0.01%	751
2022 Q2	$35K	Hold	70	–	–	﹤0.01%	726
2022 Q1	$39K	Hold	70	–	–	﹤0.01%	709
2021 Q4	$53K	Hold	70	–	–	﹤0.01%	663
2021 Q3	$52K	Hold	70	–	–	﹤0.01%	665
2021 Q2	$45K	Hold	70	–	–	﹤0.01%	674
2021 Q1	$40K	Hold	70	–	–	﹤0.01%	668
2020 Q4	$41K	Hold	70	–	–	﹤0.01%	649
2020 Q3	$36K	Hold	70	–	–	﹤0.01%	654
2020 Q2	$32K	Hold	70	–	–	﹤0.01%	648
2020 Q1	$25K	Hold	70	–	–	﹤0.01%	669
2019 Q4	$26K	Hold	70	–	–	﹤0.01%	700
2019 Q3	$23K	Hold	70	–	–	﹤0.01%	710
2019 Q2	$22K	Hold	70	–	–	﹤0.01%	716
2019 Q1	$21K	Hold	70	–	–	﹤0.01%	730
2018 Q4	$16K	Buy	+70	New	+$18.8K	﹤0.01%	764

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

WhitTier Trust Company's BIO Position: Q1 2024 in Review

WhitTier Trust Company sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2024, closing a stake of 70 shares — an estimated $22.6K sold.

WhitTier Trust Company first reported a position in BIO in Q4 2018 and held it in 21 quarters. The position peaked at $53K in Q4 2021. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

WhitTier Trust Company reported no remaining Bio-Rad Laboratories Class A position as of Q1 2024 after selling out during the quarter.
WhitTier Trust Company sold 70 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $22.6K.
WhitTier Trust Company first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 21 quarters.
WhitTier Trust Company's Bio-Rad Laboratories Class A position peaked at $53K in Q4 2021.
467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on WhitTier Trust Company's 13F filing for Q1 2024, filed 2 May 2024.